Qualigen

Qualigen 是一家在股票代码 QLGN (US) 下上市的公司。

查看带有其 6 名主要高管的组织结构图

Qualigen 搜索最多的简介

• Kevin Richardson, Interim Chief Executive Officer and Chief Financ...
• Richard David, Director
• Sidney Emery, Independent Director

高管在Qualigen变化

• Kevin Richardson已作为Interim Chief Executive Officer and Chief Financial Officer加入公司  (新闻发布的2024九月27号).
• Michael Poirier, Chairman of the Board and Chief Executive Officer, 已经离开公司  (新闻发布的2024九月27号).
• Christopher Lotz, Director, Vice President, Chief Financial Officer, 已经离开公司  (新闻发布的2024九月27号).

创建提醒
跟踪 Qualigen 的高管变动

Qualigen 拥有 992 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。

Popular M&A news in 医疗设备

• Boston Scientific 已收购 Axonics Modulation Technologies (公布2024十一月18号).
• ShiraTronics 刚刚宣布为 66 筹款数百万美元。 (公布2024十月23号).
• Johnson & Johnson 已收购 V-Wave (公布2024十月9号).

医疗设备 行业的其他推荐联系人

• Medical Microinstruments 企业 Andrew Elbardissi - Director
• Zimmer Biomet 企业 Ivan Tornos - President and Chief Executive Officer
• Illumina 企业 Frances Arnold - Director

了解更多有关医疗设备行业的信息 >

Qualigen 的最新新闻稿

• Media & Events – Qualigen Therapeutics IR Media & Events – Qualigen Therapeutics IR
• University of Louisville working on potential breakthrough COVID-19 treatment | Fox News Video
• Qualigen Therapeutics, Inc. to present at the Benzinga Biotech Small Cap Conference :: Qualigen Therapeutics, Inc. (QLGN)
• Qualigen Therapeutics, Inc. Promotes Shishir Sinha to Chief Operating Officer Position :: Qualigen Therapeutics, Inc. (QLGN)
• Qualigen Therapeutics, Inc. to present at the Oppenheimer 31st Annual Healthcare Conference :: Qualigen Therapeutics, Inc. (QLGN)
• Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL :: Qualigen Therapeutics, Inc. (QLGN)
• Qualigen Therapeutics Announces Completion of Milestone Related to the License and Technology Transfer of its FastPack® Diagnostics Products in China :: Qualigen Therapeutics, Inc. (QLGN)
• Qualigen Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference :: Qualigen Therapeutics, Inc. (QLGN)
• Qualigen Therapeutics Issues CEO Letter to Stockholders with 2021 Outlook :: Qualigen Therapeutics, Inc. (QLGN)
• Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering :: Qualigen Therapeutics, Inc. (QLGN)
• View more press releases Close

关于 Qualigen 的社交媒体

• Qualigen 在 维基百科、谷歌新闻 和 雅虎财经
• Qualigen 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Matthew Korenberg

致电Qualigen，电话：+1 760...

查看组织结构图

Register to receive your alert

报告错误